Come Together at the 2nd Pharma Omnichannel HCP Engagement Conference

Come Together at the 2nd Pharma Omnichannel HCP Engagement Conference

May 23, 2024

Lisbon, Portugal

2024-05-23

Lisbon, Portugal

Connect with us at 2nd Pharma Omnichannel HCP Engagement Conference

The Viseven team will attend the 2nd Pharma Omnichannel HCP Engagement Conference, in Lisbon on May 23-24, 2024. Nataliya Andreychuk, co-founder and CEO of Viseven, will be among the conference speakers presenting her topic: 

Exploring the Synergy Between High-Quality Content, Data, and AI in Omnichannel Marketing

Join Nataliya on May 23 at 10AM for an insightful exploration of industry-defining techniques and strategies that promise to reshape the standards of effective omnichannel communication in pharma. She will discuss the transformative impact of AI and data on content creation and how it impacts HCPs.

As the main takeaway, the attendees will learn how to leverage and integrate AI and data to deliver personalized customer experiences, enhance brand loyalty, and ultimately elevate HCP engagement.

Visitors will also have the opportunity to communicate and network with the Viseven team: Nataliya Andreychuk, CEO, Yuliya Sotska, Chief Brand & Communications Officer, Anna Zolotnytska, Head of PR, and Maciej Najdzion, Account Executive.

About
2nd Pharma Omnichannel HCP Engagement Conference

The pharma omnichannel conference will feature in-person-only roundtables, panel discussions, and engaging speeches delivered by 20+ top experts in pharma. The key objective of the event is to bring together innovators in the pharma and life science industries to share knowledge and exchange experiences. As the conference’s Gold Sponsor, the Viseven team is especially engaged in bringing real value and actionable insights to the attendees. 

Panel speakers will go over several critical topics concerning the impact of generative AI on omnichannel strategy in pharma, the impact of communication tools on communication channels in life science, the value of data-driven insights, and more.